Cardiovascular Monitoring and Diagnostic Devices Market Analysis-2027


Posted November 26, 2020 by SANJAYCMI

Cardiovascular Monitoring and Diagnostic Devices Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
 
A Holter monitor is a small, battery-powered medical device that measures your heart's activity, such as rate and rhythm whereas an Electrocardiogram (ECG) is a device that records electrical activity of the heart in waveforms with electrodes, which are placed in contact to the body (chest) and the signals are amplified on the ECG monitor.

The global Cardiovascular Monitoring And Diagnostic Devices Market is estimated to account for US$ 2,200.6 Mn in terms of value in 2020 and is expected to reach US$ 4,481.8 Mn by the end of 2027.

Global Cardiovascular Monitoring and Diagnostic Devices Market: Drivers

Approval and launch of new devices is expected to propel growth of the global cardiovascular monitoring and diagnostic devices market over the forecast period. For instance, in November 2019, Shimmer, a U.S.-based developer of wearable technology, announced that ECGmd – its five-wire, four-lead Holter monitor ECG, received CE mark.

Moreover, R&D in ECG monitoring is also expected to boost growth of the market. For instance, in May 2019, researchers from Pukyong National University, South Korea, reported designing an ECG device that is powered by solar energy with an output voltage of 2.4 V and a power out of 0.25 W.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/cardiovascular-monitoring-and-diagnostic-devices-market-4021

Global Cardiovascular Monitoring and Diagnostic Devices Market: Restraints

Inaccuracy of wearable ECG devices is expected to hinder growth of the global cardiovascular monitoring and diagnostic devices market. For instance, according to a research published in April 2019 by the Harvard Medical School, 30% of wearable devices yield inaccurate results.

Key Takeaways:

The global cardiovascular monitoring and diagnostic devices market was valued at US$ 1,987.9 Mn in 2019 and is forecast to reach a value of US$ 4,481.8 Mn by 2027 at a CAGR of 10.7% between 2020 and 2027. Major factor driving the growth of global cardiovascular monitoring and diagnostic devices market during the forecast period include high prevalence of cardiovascular diseases, and technological advancements.

ECG Monitoring Device held dominant position in the global cardiovascular monitoring and diagnostic devices market in 2019, accounting for 51.6% share in terms of value, followed by Holter Monitoring Device and ECG Stress Testing, respectively. Technological advancement is expected to support growth of the segment over the forecast period.

Market Trends

R&D in ECG-enabled smartwatch is aiding in growth of the market. For instance, in February 2020, Johnson & Johnson launched a new, virtual clinical study to determine the efficacy of Apple’s iPhone and ECG-enabled smartwatch in reducing the risk of stroke and detecting cases of atrial fibrillation.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/4021

Moreover, R&D in ECG monitoring is also boosting growth of the market. For instance, in August 2019, Emory University (U.S.) assessed the efficacy of a wearable ECG patch developed by U.S.-based VivaLNK Company in improving patient care management for patients suffering from coronary artery disease.

Global Cardiovascular Monitoring and Diagnostic Devices Market: Competitive Landscape

Major players operating in the global cardiovascular monitoring and diagnostic devices market include, GE Healthcare, Philips Healthcare, Nihon Kohden, Schiller AG, Opto Circuits (India) Limited, Welch Allyn, Fukuda Denshi Co., Ltd., Lidco Group plc, Biotricity Inc., Bittium Corporation, and VivaQuant.

Global Cardiovascular Monitoring and Diagnostic Devices Market: Key Developments

January 2020: VivaLNK, a China-based provider of connected healthcare solutions for in-patient and remote patient monitoring, received the U.S. FDA clearance for its Continuous ECG platform comprising of reusable wearable ECG sensors and associated software development kit

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4021

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- end ---
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags Cardiovascular Monitoring and Diagnostic Devices Market , Cardiovascular Monitoring and Diagnostic Devices , Cardiovascular Monitoring and Diagnostic Devices Market Share
Last Updated November 26, 2020